About
Lenire is a clinically proven, FDA-approved tinnitus treatment device developed by Neuromod Devices. It uses a patented bimodal neuromodulation approach that simultaneously delivers customized audio tones through headphones and gentle electrical pulses to the tongue via a mouthpiece called Tonguetip®. This dual-mode stimulation targets the brain's neuroplasticity to help reduce the perception of tinnitus sounds over time. Tinnitus — the persistent perception of ringing, buzzing, or other sounds with no external source — affects up to 15% of the global population and can severely impact sleep, concentration, and quality of life. Lenire specifically addresses Subjective Tinnitus, the most common form. Three large-scale clinical trials have validated Lenire's efficacy: 80% of patients in the first trial and 91% in the second reported sustained reductions in tinnitus severity lasting at least 12 months post-treatment. A third trial demonstrated significant relief for patients with moderate-to-severe tinnitus for whom sound-only therapy had no meaningful impact. Lenire is available exclusively through certified hearing care professionals and tinnitus specialists. Patients undergo an assessment to determine suitability, receive a personalized treatment plan, and use the device at home for approximately one hour per day over 12 weeks. It is trusted by veterans, professionals, and everyday people seeking a non-pharmaceutical, non-invasive path to tinnitus relief.
Key Features
- Bimodal Neuromodulation: Simultaneously delivers customized audio tones and gentle electrical pulses to the tongue, targeting the brain's neuroplasticity to retrain tinnitus perception.
- FDA-Approved & Clinically Validated: The only FDA-approved dual-mode tinnitus device, validated across three independent large-scale clinical trials showing sustained 12-month relief.
- At-Home Treatment Protocol: Patients use the device at home for approximately one hour per day over a 12-week program, prescribed and monitored by certified hearing care specialists.
- Personalized Sound Therapy: Audio stimulation is calibrated to each patient's specific tinnitus profile, maximizing effectiveness for their unique condition.
- Specialist-Supported Care Network: Delivered through a global network of certified audiologists and tinnitus specialists who provide assessment, fitting, and ongoing support.
Use Cases
- Adults suffering from moderate-to-severe Subjective Tinnitus seeking a non-pharmaceutical, clinically proven treatment option.
- Veterans and military personnel who developed tinnitus due to noise exposure and require effective, specialist-supported care.
- Patients for whom sound-only therapy or white noise masking has provided no meaningful improvement in tinnitus symptoms.
- Hearing care clinics and audiology practices looking to offer their patients an FDA-approved, evidence-based tinnitus treatment device.
- Individuals whose tinnitus is disrupting sleep, concentration, and social engagement and who want a long-term relief solution.
Pros
- Clinically Proven Long-Term Relief: Results from three large trials show 80–91% of patients experience sustained tinnitus reduction lasting at least 12 months after treatment.
- Non-Invasive & Drug-Free: Offers a pharmaceutical-free, non-surgical alternative for tinnitus sufferers who have not found relief through conventional therapies.
- FDA Regulatory Approval: Full US FDA approval gives patients and clinicians confidence in the device's safety and efficacy standards.
Cons
- Requires Professional Prescription: Cannot be purchased directly by consumers — patients must visit a certified clinic for assessment and fitting, which may limit accessibility.
- Premium Pricing: As a specialist medical device, Lenire carries a high cost that may not be covered by all insurance plans.
- Treats Subjective Tinnitus Only: The device is not indicated for Objective Tinnitus or tinnitus caused by specific medical conditions such as vascular disorders.
Frequently Asked Questions
What is Lenire and how does it work?
Lenire is an FDA-approved bimodal neuromodulation device that treats tinnitus by simultaneously playing customized audio through headphones and delivering gentle electrical pulses to the tongue. This dual stimulation leverages the brain's neuroplasticity to reduce tinnitus perception over time.
Is Lenire FDA approved?
Yes. Lenire is the first and only dual-mode tinnitus treatment device to receive US FDA approval, supported by results from three large-scale independent clinical trials.
How long does the Lenire treatment take?
The standard Lenire treatment program involves approximately one hour of use per day over 12 weeks, conducted at home after an initial clinic assessment and device fitting.
How effective is Lenire for tinnitus relief?
Clinical trials show 80% of first-trial patients and 91% of second-trial patients achieved a reduction in tinnitus severity that was sustained for at least 12 months after completing the treatment.
Where can I get Lenire?
Lenire is available exclusively through a global network of certified hearing care professionals and tinnitus specialists. Patients can use the clinic finder on Lenire's website to locate an authorized provider near them.
